Health Products

Unauthorized soft-shelled hyperbaric chambers may pose serious health risks 2026-06-16

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products - Medical devices
Product: Unauthorized soft-shelled hyperbaric chambers
Issue: Medical devices - Unauthorised device
What to do: Do not use soft-shelled hyperbaric chambers
Distribution: National
Audience: General public
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Issue

Health Canada has received several complaints related to the use of unauthorized soft-shelled hyperbaric chambers and they are increasingly found in wellness centres in Canada. Soft-shelled hyperbaric chambers are regulated as medical devices under the Food and Drugs Act and Medical Devices Regulations. These devices are unlicensed, may be ineffective for the purposes for which they are advertised and may pose serious health risks for users and those in close proximity, including death. Soft-shelled hyperbaric chambers may catch fire, especially when used in combination with an oxygen concentration device. They can suffocate users, spread infectious diseases between users, cause damage to ears, eyes, sinuses, lungs and teeth, and change blood sugar levels. To date, Health Canada has not authorized any soft-shelled hyperbaric chamber for sale in Canada, as it has not received the evidence needed to confirm that these devices meet Health Canada's safety, effectiveness or quality requirements. As a result, it is illegal to import, sell and advertise soft-shelled hyperbaric chambers in Canada. Do not confuse soft-shell hyperbaric chambers with hard-shell hyperbaric chambers. Hard-shell devices are proven to treat 14 specific conditions. You can learn more about hard-shell hyperbaric chambers on Health Canada's website. The Department is following up on complaints and will take compliance and enforcement actions, as needed, to mitigate the risk to Canadians using the most appropriate level of intervention, in accordance with its Compliance and enforcement policy for health products.